AGIO Agios Pharmaceuticals: Operatsion rentabellik

Agios Pharmaceuticals (AGIO) grafik logotipi

Agios Pharmaceuticals (AGIO) patent himoyasi va eski aktivlarni sotishdan olingan likvidlik tufayli genetik qon patologiyalari terapiyasi sohasida yetakchiligini saqlab qolmoqda. Uning noyob hujayra metabolizmi platformasi shifokorlar uchun monopol muhitni yaratadi. Biznes muvaffaqiyati tartibga soluvchi qarorlarga va dori vositalarini tijaratlashtirish sur'atiga bog'liq. GURU.Markets grafigidagi EBIT operatsion marjasi -297.70 ushbu metrikaning joriy darajasi ekanligini ko'rsatmoqda.

AGIO: agios.com Operatsion marja 04.07.2022 - 19.11.2026

AGIO (agios.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:AGIO, Agios Corp
Agios Pharmaceuticals tayyor mahsulotlari

Noaniqlik davrida kapitalni himoya qilish uchun investorlarning operatsion foyda va tushum nisbatini kuzatishi juda muhimdir, bu esa soliqlar va qarz yuklarini hisobga olmagan holda biznes samaradorligini baholash imkonini beradi. Operatsion marjani tahlil qilish orqali Agios Pharmaceuticals (AGIO) kompaniyasidagi ferment litsenziyalash va strategik ittifoqlardan kelib chiqadigan sinergiyaning innovatsion ishlanmalarni qanday qilib real operatsion samaradorlikka aylantirishini aniqlash mumkin.

Raqobatchilar tahlili

Operatsion rentabellik Ascendis|Madrigal Corp (MDGL) - Operatsion faoliyat rentabelligi|Operatsion rentabellik corcept.com (CORT)|Sotuvning operatsion marjasi rhythmtx.com RYTM|Operatsion marja AKRO (akerotx.com)|MTSR - Sotuvning operatsion marjasi|MLTX - Operatsion rentabellik|Operatsion foyda normasi CRNX (Crinetics Pharma)|NAMS (newamsterdampharma.com) - Sotuvning operatsion marjasi|SLNO (Soleno Therapeutics) - Operatsion rentabellik|FOLD (Amicus Therapeutics Inc) - Operatsion marja|Sotuvning operatsion rentabelligi 89bio Corp ETNB|Operatsion marja GPCR|MiMedx Group, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Rezolute Bio - Sotuvning operatsion marjasi|lexpharma.com (LXRX) - Sotuvning operatsion rentabelligi|MBX - Operatsion rentabellik|ALT (Altimmune) - Operatsion foyda bo'yicha sotuv rentabelligi|Aardvark Therapeutics Inc. (AARD) - Operatsion rentabellik|Sagimet - Operatsion foyda normasi|BIOA (BioAge Labs, Inc) - Operatsion marja|Operatsion marja biomeafusion.com|Operatsion marja QNCX|GUTS - Sotuvning operatsion rentabelligi|Operatsion marja VTVT (vTv Therapeutics)|ATPC - Sotuvning operatsion marjasi|PLUR - Operatsion rentabellik|Synlogic Inc. (SYBX) - Sotuvning operatsion marjasi|LPCN (Lipocine Inc) - Sotuvning operatsion marjasi|Matinas BioPharma Holdings, Inc. - Operatsion foyda normasi|SPRB (sprucebiosciences.com) - Operatsion marja|Operatsion rentabellik GLTO|Operatsion marja CTCX|Lumos Pharma, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ONVO (organovo.com)|Operatsion foyda bo'yicha marjinallik Radius Health